The cell wall is a critical structural entity for bacterial survival. Cell wall components and cell wall biosynthetic enzymes are the targets of antibiotics. A bacterial cell wall component, peptidoglycan (PG), is a disaccharide consisting of repeating N-acetylglucosamine L-Lys) attached to the D-lactyl moiety of each NAM. The pentapeptide stem participates in an interglycan crosslinking reaction, thus creating the cell wall polymer. The three-dimensional (3D) structure of two other β-1,4-glucan biopolymers, namely, cellulose (repeating glucose) and chitin (repeating NAG) has been determined; however, the 3D structure of PG has not been elucidated because of its complexity and the lack of pure and discrete segments for structural analysis. Determination of the structure of bacterial PG has been the subject of extensive investigation and speculation for the past 40 years.
Each PG strand is assumed to be crosslinked to a maximum of three neighboring PG strands. The extent of PG crosslinking in bacteria is variable, and PG crosslinking for E. coli is estimated to be less than 40%. In silico generation of the cell wall assuming incomplete crosslinks resulted in a honeycomb pattern with larger pores due to missing crosslinking.
Recently, Mobashery et al. have also reported several candidates that inhibit cell wall biosynthesis as novel targets against drug-resistant bacteria.
The penicillin-binding protein 2a (PBP 2a) from methicillin-resistant Staphylococcus aureus (MRSA) and multidrug resistant Streptococci, which can perform the critical cell wall crosslinking reaction in the presence of β-lactam antibiotics, has been used to understand the mode of action of two new β-lactam antibiotics (ceftaroline and ME1036) [Villegas-Estrada, A. et al., J. Am. Chem. Soc. (2008) 130, 9212] . These antibiotics have been reported to exert an inhibitory effect by triggering the allosteric site of PBP 2a in concert with biosynthetic intermediate of the cell wall or synthetic PG fragment, and both the antibiotics can work independently in the absence of the PG fragment. These results suggested that binding of these antibiotics at the allosteric site of PBP 2a in the absence of PG fragment entails a conformational change of PBP 2a that exposes the active site.
PG is known to be a ligand of peptide glycan recognition proteins (PGRPs), which are highly conserved pattern recognition molecules of the innate immune system, such as Toll-like receptors. Mobashery et al. reported the mechanism of binding of synthetic PG fragments with human PGRPs by using X-ray, NMR, and molecular modeling methodologies [Cho, S. et al., Proc. Natl. Acad. Sci. USA (2007) 104, 8761] ; the binding of synthetic PG fragments with human PGRPs at 0.1-1 μM concentration kills 99% bacteria. On the basis of these analyses, the PGRPs such as vancomycin were proposed to act by disrupting the cell wall maturation by sterically encumbering the access of biosynthetic enzymes to the nascent PG chains and by locking PG into a conformation that prevents the formation of crosslinks between peptide stems in the growing cell wall.
Recycling of the PG is also a very important event for bacterial survival. One of the key enzymes, AmpD (N-acetyl-1,6-anhydromuramyl-L-alanine amidase), is a peptidase that cleaves the 1,6-anhydro-N-acetylmuramylpentapeptide, which is generated from the parental cell wall by lytic transglycosylase MltB. The synthesis and properties of 1,6-anhydro-NAM (pentapeptide) derivative, an important motif for recycling, has been reported [Hasek, D. et al., J. Am. Chem. Soc. (2009) [Kawasaki, A. et al., Chem. Eur. J. (2008) 14, 10318] .
The extensive PG architecture in the bacterial cell wall and the cell wall biosynthetic enzymes continue to be the targets of antibacterials, thus enabling these antibacterials to differentiate between extremely serious pathogenic bacteria and human cells. The findings from structural analysis studies and studies on the mechanism of binding of related enzymes with respective substrates will facilitate the development of new antibacterials.
